Rectal morbidity after permanent interstitial brachytherapy for prostate cancer—Impact of Day 1 vs. Day 30 computed tomography–based postimplant dosimetry
- 31 March 2010
- journal article
- clinical trial
- Published by Elsevier in Brachytherapy
- Vol. 9 (1) , 1-7
- https://doi.org/10.1016/j.brachy.2009.04.003
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Rectal dosimetry following prostate brachytherapy with stranded seeds – Comparison of transrectal ultrasound intra-operative planning (day 0) and computed tomography-postplanning (day 1 vs. day 30) with special focus on sources placed close to the rectal wallRadiotherapy and Oncology, 2009
- Seed Displacements after Permanent Brachytherapy for Prostate Cancer in Dependence on the Prostate LevelStrahlentherapie und Onkologie, 2008
- Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapyRadiotherapy and Oncology, 2007
- Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at riskBrachytherapy, 2005
- Rectal fistulas after prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Probability of late rectal morbidity in 125I prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Defining the risk of developing Grade 2 proctitis following 125I prostate brachytherapy using a rectal dose–volume histogram analysisInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Prostatourethral-rectal fistula after prostate brachytherapyCancer, 2000
- American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1999